Gotham launches with $54 million to pursue RNA modifiers
Wednesday, October 10, 2018 - 00:41
in Astronomy & Space
The NYC-based biotech is the latest player in the nascent field of epitranscriptomics
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via